Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Ciliary body melanoma characterized by the presence of intermediate cells which are similar to but smaller than epithelioid cells.
Biomarker and diagnostic research for intermediate cell type ciliary body melanoma has been reported in the published literature.
No clinical trials have been registered for intermediate cell type ciliary body melanoma.
3 publications have been identified in PubMed for intermediate cell type ciliary body melanoma. Research spans Diagnostic / Biomarker (33%), Case Report / Case Series (33%), and Epidemiology / Natural History (33%).
Repo PE (2025). [PMID: 39344744](https://pubmed.ncbi.nlm.nih.gov/39344744/). *Pigment cell & melanoma research*. [Epidemiology / Natural History]
Obuchowska I (2025). [PMID: 40826825](https://pubmed.ncbi.nlm.nih.gov/40826825/). *Medical science monitor : international medical journal of experimental and clinical research*. [Diagnostic / Biomarker]
Murty T (2025). [PMID: 40475129](https://pubmed.ncbi.nlm.nih.gov/40475129/). *American journal of ophthalmology case reports*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 5:23 PM UTC